Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab

BACKGROUND: Predicting how patients with central retinal vein occlusion (CRVO) will respond to intravitreal anti-VEGF is challenging. The purpose of this study was to identify pre-treatment clinical features in CRVO that predict visual acuity (VA) following intravitreal ranibizumab. METHODS: Medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Brogan, Kerr, Precup, Monica, Rodger, Amanda, Young, David, Gilmour, David Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807839/
https://www.ncbi.nlm.nih.gov/pubmed/29426292
http://dx.doi.org/10.1186/s12886-018-0701-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807839/
https://www.ncbi.nlm.nih.gov/pubmed/29426292
http://dx.doi.org/10.1186/s12886-018-0701-x

Ejemplares similares